Navigation Links
Cambridge Healthtech Institute to Host Its Second Annual Collaborative Innovation in Biomedicine Conference
Date:4/30/2010

Strategies and Best Practices for Pre-Competitive Sharing of Data, Results and Costs

Needham, MA (PRWEB) April 30, 2010 -- Cambridge Healthtech Institute will host its second annual Collaborative Innovation in Biomedicine conference on June 14-16, 2010 in Philadelphia, PA. The biomedical industry is under enormous pressure to produce faster results, while also finding ways to reduce costs. Examples abound in one industry after another of how researchers have gained tremendous advantages by collaborating on pre-competitive efforts, but such efforts have been limited in biomedical research, where researchers often find it difficult to openly share data within their own organization, much less with competitors. This conference aims to bring together a number of experts with practical experience in organizing, managing, funding, and getting results from pre-competitive collaborative projects. Speakers will talk from first-hand experience about what works and what doesn't as the program explores the most important new models, key issues, challenges and best practices of Collaborative Innovation in Biomedicine.

"Given the number of challenges that the industry is facing," says Phillips Kuhl, President of Cambridge Healthtech Institute, "There is clearly a need for new models and approaches. A key goal of the program is to provide attendees with a number of key strategies for identifying when and how collaborative innovation can and should be encouraged, as well as when such efforts are less likely to produce useful results."

The conference program will deal with topics such as case studies of successful consortia and collaborations; strategies for dealing with the challenge of shared intellectual property; strategies and technology for facilitating data sharing; novel approaches for identifying collaborative information and partners; collaborative development and evaluation of new technology and software; and more. The conference will feature speakers with first-hand experience in setting up and running successful consortia.

Featured speakers include a number of representatives from large pharma: Jackie Hunter, Ph.D., Senior Vice President, Science Environment Development, GlaxoSmithKline; Robin Spencer, Ph.D., Senior Fellow, Research Centers of Emphasis, Pfizer, Inc.; Stefan J. Platz, Ph.D., Head, Toxicology & Pathology, F. Hoffman-LaRoche Ltd.; David Cook, Ph.D., Global Safety Assessment, AstraZeneca Pharmaceuticals; Bryn Williams-Jones, Ph.D., Associate Research Fellow; Head, eBiology, Pfizer; and Ramesh Durvasula, Ph.D., Director, Chemistry Informatics, Research Informatics & Automation, Bristol-Myers Squibb.

In addition, case studies of emerging consortia-based models and best practices will be presented by representatives from consortia, not-for-profit and academics, as well as executives from technology/biotechnology companies: Eric Thompson, Ph.D., Assistant Director, Predictive Safety Testing Consortium, Critical Path Institute; Robert Porter-Lynch, Ph.D., CEO, The Warren Group; Managing Partner, System of Trust, LLC; Les Jordan, Chief Technology Strategist, Microsoft Life Sciences; Sean Ekins, Ph.D., Collaborations Director, Research & Development, Collaborative Drug Discovery; Jean-Robert Ioset, Professor, Project Coordinator, Research & Development, Drugs for Neglected Diseases initiative (DNDi); Max Fehlmann, Ph.D., President & CEO, Quebec Consortium of Drug Discovery; Mariana Guergova-Kuras, Ph.D., Director of Research, Biosystems International; Shawnmarie Mayrand-Chung, Ph.D., NIH Director for The Biomarkers Consortium & Senior Advisor to The Biomarkers Consortium; Syril D. Pettit, Ph.D., MEM, Associate Director, HESI, ILSI; John Overington, Ph.D., Team Leader, Chemogenomics, EMBL-EBI, Wellcome Trust Genome Campus; and Sandor Szalma, Ph.D., Senior Research Fellow, Research & Development Informatics, Centocor R&D, Inc.

The Collaborative Innovation in Biomedicine conference is immediately followed by CHI's inaugural Encouraging Development of Therapeutics for Neglected Diseases conference being held June 16-17, 2010. Cambridge Healthtech Institute offers package pricing to attendees interested in participating in both conferences.

Please visit www.healthtech.com/cbi for more information.

About Cambridge Healthtech Institute (CHI)
Founded in 1992, Cambridge Healthtech Institute (CHI) (www.chicorporate.com) is the industry leader offering the preeminent source of information to the leading researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, and Cambridge Healthtech Media Group.

Contact: Kaushik Chaudhuri
Cambridge Healthtech Institute
(781) 972-5419
kchaudhuri(at)healthtech(dot)com

###

Read the full story at http://www.prweb.com/releases/2010/04/prweb3947754.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Christine P. Carrington, President of NurseTesting Creative Solutions, Inducted into Cambridge Who's Who
2. Cambridge Healthtech Announces Its Inaugural Encouraging Development of Therapeutics for Neglected Diseases Conference
3. Rush Limbaugh & Michael Steele Join Tea Party Support & Social Security Institute-Demand GOP Senate Stop ObamaCare by Any Means Possible
4. MRI Partners with Natural Marketing Institute
5. Traceability Institute Comments on Improving Food Safety System for Consumers at Food and Drug Administration (FDA) and Food Safety and Inspection Service (FSIS) Joint Public Meeting
6. Institute for Healthcare Advancement's Ninth Annual Health Literacy Conference Set for May 6-7, 2010 in Irvine, Calif.
7. Biomedical Industry Jobs Critical to California's Economic Recovery, Finds California Healthcare Institute and PricewaterhouseCoopers
8. The Colorado Institute for Drug, Device and Diagnostic Development Launches With a Statewide Call for Proposals From Life Science Technologies in Need of Funding and Active Management
9. Karmanos Cancer Institute in Detroit Names Gerold Bepler, M.D., Ph.D., as CEO
10. NASA selects DNA Medicine Institutes Nanoscale Diagnostics Technology for Phase II SBIR
11. The Andrews Institute and Reebok Join Partner Roster for USA Football's “Team USA vs. The World” Game, Presented By Riddell
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever ... Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation ... as home to some of the world’s leading providers of cereal and other breakfast ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology: